Leap Therapeutics Says New Data Show Sirexatamab Improves Survival in Colorectal Cancer Trial
In This Article:
Leap Therapeutics (LPTX) said Wednesday that updated findings from its phase 2 trial indicate that s
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.